Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll‐Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double‐Blind, Placebo‐Controlled Study

Documenti analoghi

• Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis
  di: Yurilu A. Gonzalez Moret, et al.
  Pubblicazione: (2024)
• Urinary Incontinence Among Adults With Systemic Lupus Erythematosus
  di: Gabriel Salazar, et al.
  Pubblicazione: (2025)
• Falls Among Individuals With Systemic Lupus Erythematosus: An Observational Study
  di: Chelsea R. Perfect, et al.
  Pubblicazione: (2025)
• Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model
  di: Amanda M. Eudy, et al.
  Pubblicazione: (2024)
• Social Connections in Older Adults With Systemic Lupus Erythematosus: Patient Perspectives
  di: Sarah B. Lieber, et al.
  Pubblicazione: (2025)